# 10x Genomics, Inc. (TXG)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/TXG/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 150.84M | $ -13.47M | $ 24.52M | $ 81.39M | $ 814.32M |
| 2025 | $ 658.19M | $ -44.59M | $ 133.23M | $ 157.74M | $ 796.33M |
| 2024 | $ 641.98M | $ -191.96M | $ -7.07M | $ 82.61M | $ 710.13M |
| 2023 | $ 669.00M | $ -275.83M | $ -69.20M | $ 95.37M | $ 741.04M |
| 2022 | $ 576.88M | $ -185.44M | $ -184.62M | $ 95.18M | $ 805.74M |
| 2021 | $ 583.02M | $ -69.21M | $ -145.79M | $ 81.98M | $ 817.57M |
| 2020 | $ 380.71M | $ -691.40M | $ -326.50M | $ 62.98M | $ 739.07M |
| 2019 | $ 317.39M | $ -40.34M | $ -10.51M | $ 29.72M | $ 420.08M |
| 2018 | $ 196.10M | $ -142.11M | $ -109.77M | $ 29.68M | $ -219.99M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.10 |
| Liabilities / Eq | 0.25 |
| Current Ratio | 5.90 |

## Other views

- [Metrics](https://sponda.capital/en/TXG.md)
- [Charts](https://sponda.capital/en/TXG/charts.md)
- [Compare](https://sponda.capital/en/TXG/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.